NCT04846686View on ClinicalTrials.gov

Placental Expression of EG-VEGF and Its PROKR1 and PROKR2 Receptors in Preeclampsia Patients.

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

January 1, 2023

Conditions
Preeclampsia
Interventions
BIOLOGICAL

Placenta pathological examination

a placenta pathological examination will be analyzed to examine quantification of EG-VEGF, PROKR1 and PROKR2 receptors.

Trial Locations (1)

Unknown

Chu Saint-Etienne, Saint-Etienne

All Listed Sponsors
collaborator

Commissariat A L'energie Atomique

OTHER_GOV

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER